The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

14 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design, synthesis, and characterization of an ATP-peptide conjugate inhibitor of protein kinase A.EBI
Johns Hopkins University School of Medicine
Identification of allosteric binding sites for PI3Ka oncogenic mutant specific inhibitor design.EBI
Johns Hopkins University School of Medicine
Design, synthesis, and structure-activity relationships of pyridoquinazolinecarboxamides as RNA polymerase I inhibitors.EBI
Johns Hopkins University School of Medicine
Pyridinylquinazolines selectively inhibit human methionine aminopeptidase-1 in cells.EBI
Johns Hopkins University School of Medicine
Bisubstrate ketone analogues as serotonin N-acetyltransferase inhibitors.EBI
Johns Hopkins University School of Medicine
Mechanism and inhibition of cytochrome P-450 aromatase.EBI
Johns Hopkins University School of Medicine
Chemical probes for histone-modifying enzymes.EBI
Johns Hopkins University School of Medicine
Analogs of JHU75528, a PET ligand for imaging of cerebral cannabinoid receptors (CB1): development of ligands with optimized lipophilicity and binding affinity.EBI
Johns Hopkins University School of Medicine
Effects of 6-Aminonicotinic Acid Esters on the Reprogrammed Epigenetic State of Distant Metastatic Pancreatic Carcinoma.EBI
Johns Hopkins University School of Medicine
A Novel, Selective c-Abl Inhibitor, Compound 5, Prevents Neurodegeneration in Parkinson's Disease.EBI
Johns Hopkins University School of Medicine
Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis.EBI
Johns Hopkins University School of Medicine
Synthesis and characterization of novel isoform-selective IP6K1 inhibitors.EBI
Johns Hopkins University School of Medicine
Inhibition of human placental aromatase by novel homologated 19-oxiranyl and 19-thiiranyl steroids.EBI
Johns Hopkins University School of Medicine
Novel bisubstrate analog inhibitors of serotonin N-acetyltransferase: the importance of being neutral.BDB
Johns Hopkins University School of Medicine